Research progress of PD-1/PD-L1 inhibitors in the treatment of peripheral T-cell lymphomas
Peripheral T-cell lymphomas (PTCLs) are a group of highly heterogeneous and aggressive non-Hodgkin’s lymphoma (NHL). PTCL patients have poor prognosis and high rates of relapse under the current chemotherapy-based treatment. Therefore, new drugs should be developed to improve the prognosis of PTCL....
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Editorial Office of China Oncology
2020-01-01
|
| סדרה: | Zhongguo aizheng zazhi |
| נושאים: | |
| גישה מקוונת: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2020.12.012 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
